A cancer therapeutic nanoparticle vaccine targeting HAAH improves 3-week survival from 12.5% to 100% in a mouse model of metastatic breast cancer

Lignende værker

• Inhibition of tumor growth in vivo by a nanoparticle-based therapeutic cancer vaccine targeting HAAH
  af: Fuller, Steven, et al.
  Udgivet: (2013)
• A nanoparticle therapeutic vaccine targeting HAAH stimulates cellular immunity
  af: Lebowitz, Michael, et al.
  Udgivet: (2015)
• Immunogenicity of a lambda phage-based anti-cancer vaccine targeting HAAH
  af: Fuller, Steven, et al.
  Udgivet: (2013)
• Enhanced immunogenicity of a nanoparticle therapeutic cancer vaccine targeting HAAH delivered intradermally using 3M's hollow microstructured transdermal system (hMTS)
  af: Fuller, Steven, et al.
  Udgivet: (2015)
• Design, development and production of nano-particle-based anticancer vaccine targeting human aspartyl (asparaginyl) β-hydroxylase (HAAH)
  af: Biswas, Biswajit, et al.
  Udgivet: (2013)